Trial Profile
A Therapeutic-equivalence Study Comparing The Efficacy And Safety Of Subcutaneous Epoetin Hospira And Epoetin Alfa (Amgen) In Patients With Chronic Renal Failure Requiring Hemodialysis And Receiving Epoetin Maintenance Treatment
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Epoetin zeta (Primary) ; Epoetin alfa
- Indications Anaemia
- Focus Registrational; Therapeutic Use
- Acronyms AiME - 13
- Sponsors Hospira
- 15 Apr 2014 New trial record